| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Cancer Immunology Program, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL 60153
Human papillomavirus (HPV)-derived chimeric virus-like particles (VLPs) are the leading candidate vaccine for the treatment or prevention of cervical cancer in humans. Dendritic cells (DCs) are the most potent inducers of immune responses and here we show for the first time evidence for binding of chimeric HPV-16 VLPs to human peripheral blood-derived DCs. Incubation of immature human DCs with VLPs for 48 h induced a significant up-regulation of the CD80 and CD83 molecules as well as secretion of IL-12. Confocal microscopy analysis revealed that cell surface-bound chimeric VLPs were taken up by DCs. Moreover, DCs loaded with chimeric HPV-16 L1L2-E7 VLPs induced an HLA-*0201-restricted human T cell response in vitro specific for E7-derived peptides. These results clearly demonstrate that immature human DCs are fully activated by chimeric HPV-16 VLPs and subsequently are capable of inducing endogenously processed epitope-specific human T cell responses in vitro. Overall, these findings could explain the high immunogenicity and efficiency of VLPs as vaccines.
This article has been cited by other articles:
|
|
 |
|
  A. M. Didierlaurent, S. Morel, L. Lockman, S. L. Giannini, M. Bisteau, H. Carlsen, A. Kielland, O. Vosters, N. Vanderheyde, F. Schiavetti, et al. AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity J. Immunol., November 15, 2009; 183(10): 6186 - 6197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Fahey, A. B. Raff, D. M. Da Silva, and W. M. Kast A Major Role for the Minor Capsid Protein of Human Papillomavirus Type 16 in Immune Escape J. Immunol., November 15, 2009; 183(10): 6151 - 6156. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schellenbacher, R. Roden, and R. Kirnbauer Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines J. Virol., October 1, 2009; 83(19): 10085 - 10095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Perrone, A. Ahmad, V. Veguilla, X. Lu, G. Smith, J. M. Katz, P. Pushko, and T. M. Tumpey Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge J. Virol., June 1, 2009; 83(11): 5726 - 5734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Fahey, A. B. Raff, D. M. Da Silva, and W. M. Kast Reversal of Human Papillomavirus-Specific T Cell Immune Suppression through TLR Agonist Treatment of Langerhans Cells Exposed to Human Papillomavirus Type 16 J. Immunol., March 1, 2009; 182(5): 2919 - 2928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Garcia-Pineres, A. Hildesheim, L. Dodd, T. J. Kemp, J. Yang, B. Fullmer, C. Harro, D. R. Lowy, R. A. Lempicki, and L. A. Pinto Gene Expression Patterns Induced by HPV-16 L1 Virus-Like Particles in Leukocytes from Vaccine Recipients J. Immunol., February 1, 2009; 182(3): 1706 - 1729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Barth, E. K. Schnober, C. Neumann-Haefelin, C. Thumann, M. B. Zeisel, H. M. Diepolder, Z. Hu, T. J. Liang, H. E. Blum, R. Thimme, et al. Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells J. Virol., April 1, 2008; 82(7): 3466 - 3479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mattil-Fritz, D. Scharner, K. Piuko, N. Thones, L. Gissmann, H. Muller, and M. Muller Immunotherapy of equine sarcoid: dose-escalation trial for the use of chimeric papillomavirus-like particles J. Gen. Virol., January 1, 2008; 89(1): 138 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Da Silva, S. C. Fausch, J. S. Verbeek, and W. M. Kast Uptake of Human Papillomavirus Virus-Like Particles by Dendritic Cells Is Mediated by Fc{gamma} Receptors and Contributes to Acquisition of T Cell Immunity J. Immunol., June 15, 2007; 178(12): 7587 - 7597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. S. Liu, J. Dyer, G. R. Leggatt, G. J. P. Fernando, J. Zhong, R. Thomas, and I. H. Frazer Overcoming Original Antigenic Sin to Generate New CD8 T Cell IFN-{gamma} Responses in an Antigen-Experienced Host. J. Immunol., September 1, 2006; 177(5): 2873 - 2879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Yang, F. M. Murillo, M. J. Delannoy, R. L. Blosser, W. H. Yutzy IV, S. Uematsu, K. Takeda, S. Akira, R. P. Viscidi, and R. B. S. Roden B Lymphocyte Activation by Human Papillomavirus-Like Particles Directly Induces Ig Class Switch Recombination via TLR4-MyD88 J. Immunol., June 15, 2005; 174(12): 7912 - 7919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bousarghin, P. Hubert, E. Franzen, N. Jacobs, J. Boniver, and P. Delvenne Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells J. Gen. Virol., May 1, 2005; 86(5): 1297 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Barth, A. Ulsenheimer, G. R. Pape, H. M. Diepolder, M. Hoffmann, C. Neumann-Haefelin, R. Thimme, P. Henneke, R. Klein, G. Paranhos-Baccala, et al. Uptake and presentation of hepatitis C virus-like particles by human dendritic cells Blood, May 1, 2005; 105(9): 3605 - 3614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Boisgerault, P. Rueda, C. M. Sun, S. Hervas-Stubbs, M. Rojas, and C. Leclerc Cross-Priming of T Cell Responses by Synthetic Microspheres Carrying a CD8+ T Cell Epitope Requires an Adjuvant Signal J. Immunol., March 15, 2005; 174(6): 3432 - 3439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhang, R. Fayad, X. Wang, D. Quinn, and L. Qiao Human Immunodeficiency Virus Type 1 Gag-Specific Mucosal Immunity after Oral Immunization with Papillomavirus Pseudoviruses Encoding Gag J. Virol., October 1, 2004; 78(19): 10249 - 10257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Engelmark, A. Beskow, J. Magnusson, H. Erlich, and U. Gyllensten Affected sib-pair analysis of the contribution of HLA class I and class II loci to development of cervical cancer Hum. Mol. Genet., September 1, 2004; 13(17): 1951 - 1958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Yang, F. M. Murillo, K.-Y. Lin, W. H. Yutzy IV, S. Uematsu, K. Takeda, S. Akira, R. P. Viscidi, and R. B. S. Roden Human Papillomavirus Type-16 Virus-Like Particles Activate Complementary Defense Responses in Key Dendritic Cell Subpopulations J. Immunol., August 15, 2004; 173(4): 2624 - 2631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Yao, R. Zhang, L. Guo, M. Li, and C. Chen Th Cell-Independent Immune Responses to Chimeric Hemagglutinin/Simian Human Immunodeficiency Virus-Like Particles Vaccine J. Immunol., August 1, 2004; 173(3): 1951 - 1958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mandic and T. Vujkov Human papillomavirus vaccine as a new way of preventing cervical cancer: a dream or the future? Ann. Onc., February 1, 2004; 15(2): 197 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. B. Buck, D. V. Pastrana, D. R. Lowy, and J. T. Schiller Efficient Intracellular Assembly of Papillomaviral Vectors J. Virol., January 15, 2004; 78(2): 751 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tsunetsugu-Yokota, Y. Morikawa, M. Isogai, A. Kawana-Tachikawa, T. Odawara, T. Nakamura, F. Grassi, B. Autran, and A. Iwamoto Yeast-Derived Human Immunodeficiency Virus Type 1 p55gag Virus-Like Particles Activate Dendritic Cells (DCs) and Induce Perforin Expression in Gag-Specific CD8+ T Cells by Cross-Presentation of DCs J. Virol., October 1, 2003; 77(19): 10250 - 10259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Biemelt, U. Sonnewald, P. Galmbacher, L. Willmitzer, and M. Muller Production of Human Papillomavirus Type 16 Virus-Like Particles in Transgenic Plants J. Virol., September 1, 2003; 77(17): 9211 - 9220. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Devaraj, M. L. Gillison, and T.-C. Wu DEVELOPMENT OF HPV VACCINES FOR HPV-ASSOCIATED HEAD AND NECK SQUAMOUS CELL CARCINOMA Critical Reviews in Oral Biology & Medicine, September 1, 2003; 14(5): 345 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. G. Moron, P. Rueda, C. Sedlik, and C. Leclerc In Vivo, Dendritic Cells Can Cross-Present Virus-Like Particles Using an Endosome-to-Cytosol Pathway J. Immunol., September 1, 2003; 171(5): 2242 - 2250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Davidson, P. Sehr, R. L. Faulkner, J. L. Parish, K. Gaston, R. A. Moore, M. Pawlita, H. C. Kitchener, and P. L. Stern Human papillomavirus type 16 E2- and L1-specific serological and T-cell responses in women with vulval intraepithelial neoplasia J. Gen. Virol., August 1, 2003; 84(8): 2089 - 2097. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Fausch, D. M. Da Silva, and W. M. Kast Differential Uptake and Cross-Presentation of Human Papillomavirus Virus-like Particles by Dendritic Cells and Langerhans Cells Cancer Res., July 1, 2003; 63(13): 3478 - 3482. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ohlschlager, W. Osen, K. Dell, S. Faath, R. L. Garcea, I. Jochmus, M. Muller, M. Pawlita, K. Schafer, P. Sehr, et al. Human Papillomavirus Type 16 L1 Capsomeres Induce L1-Specific Cytotoxic T Lymphocytes and Tumor Regression in C57BL/6 Mice J. Virol., April 15, 2003; 77(8): 4635 - 4645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Chackerian, P. Lenz, D. R. Lowy, and J. T. Schiller Determinants of Autoantibody Induction by Conjugated Papillomavirus Virus-Like Particles J. Immunol., December 1, 2002; 169(11): 6120 - 6126. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Weijzen, M. P. Velders, A. G. Elmishad, P. E. Bacon, J. R. Panella, B. J. Nickoloff, L. Miele, and W. M. Kast The Notch Ligand Jagged-1 Is Able to Induce Maturation of Monocyte-Derived Human Dendritic Cells J. Immunol., October 15, 2002; 169(8): 4273 - 4278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Fausch, D. M. Da Silva, M. P. Rudolf, and W. M. Kast Human Papillomavirus Virus-Like Particles Do Not Activate Langerhans Cells: A Possible Immune Escape Mechanism Used by Human Papillomaviruses J. Immunol., September 15, 2002; 169(6): 3242 - 3249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Moingeon, C. de Taisne, and J. Almond Delivery technologies for human vaccines Br. Med. Bull., July 1, 2002; 62(1): 29 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Moron, P. Rueda, I. Casal, and C. Leclerc CD8{alpha}2 CD11b+ Dendritic Cells Present Exogenous Virus-like Particles to CD8+ T Cells and Subsequently Express CD8{alpha} and CD205 Molecules J. Exp. Med., May 20, 2002; 195(10): 1233 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Shi, J. Liu, Y. Huang, and L. Qiao Papillomavirus Pseudovirus: a Novel Vaccine To Induce Mucosal and Systemic Cytotoxic T-Lymphocyte Responses J. Virol., November 1, 2001; 75(21): 10139 - 10148. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
